advertisement
11.4 Prostaglandins (19)
Showing records 1 to 19
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins27014 Evaluation of prostaglandin analogue effects on corneal keratocyte density using scanning laser confocal microscopy.
Bergonzi C; Giani A; Blini M; Marchi S; Luccarelli S; Staurenghi G
Journal of Glaucoma 2010; 19: 617-621
27027 Effects of prostaglandin F(2α) analogues on endothelin-1-induced impairment of rabbit ocular blood flow: comparison among tafluprost, travoprost, and latanoprost.
Kurashima H; Watabe H; Sato N; Abe S; Ishida N; Yoshitomi T
Experimental Eye Research 2010; 91: 853-859
27110 The additive effect of dorzolamide hydrochloride (Trusopt) and a morning dose of bimatoprost (Lumigan) on intraocular pressure and retrobulbar blood flow in patients with primary open-angle glaucoma
Stankiewicz A; Wierzbowska J; Siemiatkowska A; Fuksinska B; Robaszkiewicz J; Zegadlo A; Ehrlich R; Siesky B; Harris A
British Journal of Ophthalmology 2010; 94: 1307-1311
27498 Effect of travoprost on 24-hour intraocular pressure in normal tension glaucoma
Nomura Y; Nakakura S; Moriwaki M; Takahashi Y; Shiraki K
Clinical Ophthalmology 2010; 4: 643-647
27306 Hypertrichosis of the upper cheek area associated with travoprost treatment of glaucoma
Ortiz-Perez S; Olver JM
Ophthalmic Plastic and Reconstructive Surgery 2010; 26: 376-377
27531 Comparative study of three prostaglandin analogues in the treatment of newly diagnosed cases of ocular hypertension, open-angle and normal tension glaucoma
Faridi UA; Saleh TA; Ewings P; Venkateswaran M; Cadman DH; Samarasinghe RA; Vodden J; Claridge KG
Clinical and Experimental Ophthalmology 2010; 38: 678-682
27494 Efficacy and patient tolerability of travoprost bak-free solution in patients with open-angle glaucoma and ocular hypertension
Mirza SK; Johnson SM
Clinical Ophthalmology 2010; 4: 877-888
27364 Study of iris color change after use of travoprost
Huang P; Zhong Z; Wu L-L; Liu W-H
Chinese Ophthalmic Research 2010; 28: 869-872
27436 Enhancing the growth of natural eyelashes: The mechanism of bimatoprost-induced eyelash growth
Cohen JL
Dermatologic Surgery 2010; 36: 1361-1371
27394 Twenty-four-hour intraocular pressure control with latanoprost-timolol-fixed combination versus bimatoprost in patients who switched from Timolol
Mesci C; Aydin N; Erbil HH
Journal of Glaucoma 2010;
27441 A meta-analysis of the peer-reviewed literature on topical prostaglandin analogues: Demonstration of a tool for making evidence-based decisions for managed care formularies
Kymes S; Burk C; Feinman T; Williams J; Hollander D
Journal of Managed Care Pharmacy 2010; 16: 515
27517 Monotherapy with lipid structural derivatives in glaucoma
Calugaru D; Calugaru M
Oftalmologia 2010; 54: 30-43
27508 Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension
Lee AJ; McCluskey P
Clinical Ophthalmology 2010; 4: 741-764
27192 The utility of the monocular trial: Data from the ocular hypertension treatment study
Bhorade AM; Wilson BS; Gordon MO; Palmberg P; Weinreb RN; Miller E; Chang RT; Kass MA
Ophthalmology 2010; 117: 2047-2054
27575 Cellular basis for bimatoprost effects on human conventional outflow
Stamer WD; Piwnica D; Jolas T; Carling RW; Cornell CL; Fliri H; Martos J; Pettit SN; Wang JW; Woodward DF
Investigative ophthalmology & visual science 2010; 51: 5176-5181
27193 The intraocular pressure-lowering effect of prostaglandin analogs combined with topical (beta)-blocker therapy: A systematic review and meta-analysis
Webers CAB; Beckers HJM; Zeegers MP; Nuijts RMMA; Hendrikse F; Schouten JSAG
Ophthalmology 2010; 117: 2067-2074
27492 Mirtogenol((registered trademark)) potentiates latanoprost in lowering intraocular pressure and improves ocular blood flow in asymptomatic subjects
Steigerwalt Jr RD; Belcaro G; Morazzoni P; Bombardelli E; Burki C; Schonlau F
Clinical Ophthalmology 2010; 4: 471-476
27502 Cytotoxicity of prostaglandin analog eye drops preserved with benzalkonium chloride in multiple corneoconjunctival cell lines
Ayaki M; Iwasawa A
Clinical Ophthalmology 2010; 4: 919-924
27247 First-year treatment costs among new initiators of topical prostaglandin analog identified from November 2007 through April 2008
Schmier JK; Covert DW; Robin AL
Current Medical Research and Opinion 2010; 26: 2769-2777
